Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Meningioma × Dexmedetomidine × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pain, Postoperative 12 Brain Neoplasms 8 Breast Neoplasms 5 Agnosia 4 Thyroid Neoplasms 3 Stomach Neoplasms 3 Lung Neoplasms 3 Emergence Delirium 3 Colorectal Neoplasms 3 Urinary Bladder Neoplasms 2 Prostatic Neoplasms 2 Pain 2 Inflammation 2 Dexmedetomidine 2 Delirium 2 Chronic Pain 2 Thrombosis 1 Supratentorial Neoplasms 1 Sigmoid Neoplasms 1 Sedation 1 Sarcoma 1 Retinoblastoma 1 Rectal Neoplasms 1 Prostatic Hyperplasia 1 Postoperative Nausea and Vomiting 1 Pneumoperitoneum 1 Pheochromocytoma 1 Opioid Consumption, Postoperative 1 Neoplasms 1 Neoplasm Metastasis 1

Interventions

Magnetic Resonance Spectroscopy 4 Yoga 2 Sodium Chloride 2 Saline Solution 2 Ropivacaine 2 Proton Therapy 2 Gadolinium DTPA 2 Elasticity Imaging Techniques 2 sintilimab 1 gallium Ga 68 dotatate 1 gadobutrol 1 gadobenic acid 1 apatinib 1 Tranexamic Acid 1 Thrombectomy 1 Surveys and Questionnaires 1 Spinal Puncture 1 Restraint, Physical 1 Radiotherapy, Image-Guided 1 Radiosurgery 1 Radiation Dose Hypofractionation 1 Protons 1 Neuropsychological Tests 1 Mind-Body Therapies 1 Meditation 1 Laser Speckle Contrast Imaging 1 Immunoenzyme Techniques 1 Hyperspectral Imaging 1 Heavy Ion Radiotherapy 1 Gelclair 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07398066 2026-02-09

DEX-NEURO

University of Malaya

Phase NA Not yet recruiting

Brain Neoplasms, Delirium, Meningioma, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡